Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jason Vittitow"'
Publikováno v:
Current Therapeutic Research, Vol 98, Iss , Pp 100704- (2023)
ABSTRACT: Objective: Perfluorohexyloctane (PFHO) MIEBOTM, formerly (NOV03) is a single component, water-free eye drop approved by the Food and Drug Administration in the United States for the treatment of dry eye disease. We evaluated the in vitro in
Externí odkaz:
https://doaj.org/article/c64dbd39148c43218c532cd462cacaef
Publikováno v:
Current Therapeutic Research, Vol 98, Iss , Pp 100705- (2023)
ABSTRACT: Objective: One-hundred percent perfluorohexyloctane (PFHO) is a water-free, preservative-free eye drop approved by the Food and Drug Administration in the United States for the treatment of dry eye disease. PFHO has shown relief of dry eye
Externí odkaz:
https://doaj.org/article/ded10b4e5a2a43649db782e8f3ee55b2
Autor:
Abby Jacobson, Nadege Gunn, Mark Lebwohl, Robert J. Israel, Jason Vittitow, Ronald Prussick, Susan Harris
Publikováno v:
SKIN The Journal of Cutaneous Medicine. 3:S20
not available.
Publikováno v:
Ophthalmology. 123(5)
To compare the diurnal intraocular pressure (IOP)-lowering effect of latanoprostene bunod (LBN) ophthalmic solution 0.024% every evening (qpm) with timolol maleate 0.5% twice daily (BID) in subjects with open-angle glaucoma (OAG) or ocular hypertensi
Publikováno v:
The Journal of Sexual Medicine. 14:e331-e331
Autor:
Thierry Amar, José L. Boyer, Christopher S Crean, Jason Vittitow, Kendall D. Powell, Rozemarijn S. Verhoeven, Esen K. Akpek, Kurt E. Brubaker
Publikováno v:
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics. 25(5)
To investigate the ocular distribution of 1% azithromycin ophthalmic solution and the effect of polycarbophil-based mucoadhesive formulation on ocular tissue levels of azithromycin after single and multiple topical administrations in the rabbit eye.R
Autor:
Jason, Vittitow, Teresa, Borrás
Publikováno v:
Journal of cellular physiology. 201(1)
Physiological pressure inside the eye is maintained by a resistance mechanism provided by the trabecular meshwork tissue. In most cases, prolonged, elevated pressure leads to an eye pathology characterized by retinal ganglion cell (RGC) degeneration,